Dasatinib (BMS-35482) Interacts Synergistically With Docetaxel, Gemcitabine, Topotecan, and Doxorubicin in Ovarian Cancer Cells With High SRC Pathway Activation and Protein Expression
Angeles Alvarez Secord, Deanna Teoh, Jingquan Jia, Andrew B. Nixon, Lisa Grace, David J. Adams, Susan K. Murphy
International Journal of Gynecologic Cancer Feb 2014, 24 (2) 218-225; DOI: 10.1097/IGC.0000000000000056